Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of ASP1585 (Bixalomer) in CKD Patients with Hyperphosphatemia on Hemodialysis
NCT00892749Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2009
- Primary completion
- Sep 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bixalomer in hyperphosphatemia, sponsored by Astellas Pharma. Started May 2009; status: completed.
02
Drugs
bixalomer
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00892749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892749.